BSEBoard Meeting2d ago · 23 Oct 2026, 07:09 pm

Bandaram Pharma Packtech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 ,inter alia, to consider and approve 1. Un-audited standalone and consolidated financial results along with Limited Review Report for the quarter ended 30.09.2026. 2. Any other business with the permission of the Chair.

Bandaram Pharma Packtech Ltd · 524602

✦ AI SummaryResults

Bandaram Pharma Packtech Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 29/10/2026 to consider un-audited standalone and consolidated financial results for the quarter ended 30.09.2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk3/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Bandaram Pharma Packtech Ltd - 524602 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 29.10.2026

Attachments (1)

📄

1cc781e4-2c8a-4d64-9ab3-b8c2c1f8c4b9.pdf

pdf

Download →
View document text
To, Date: 23.10.2026 BSE Limited, P.J. Towers, Dalal Street, Mumbai-400001 Sub: Intimation of Board meeting to be held on 29.10.2026 Unit: Bandaram Pharma Packtech Limited (Scrip Code: 524602) Dear Sir/Madam, With reference to the above-mentioned subject, this is to inform the Exchange that the meeting of the Board of Directors of Bandaram Pharma Packtech Limited will be held on Thursday, the 29th day of October, 2026 at the registered office of the company to consider the following: 1. Un-audited standalone and consolidated financial results along with Limited Review Report for the quarter ended 30.09.2026. 2. Any other business with the permission of the Chair. This is to further inform you that as per Regulation 9 of the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code of Conduct for Prevention of Insider Trading (the "Code of Conduct") framed in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, the trading window for dealing in the securities is already closed from 01.10.2026 till 48 hours after the declaration of un-audited financial results for the quarter ending on 30.09.2026, for all connected persons / officers / designated employees / insiders, directors of the Company and immediate relatives of these persons, including but not limited to the persons specified in the Company's Code of Conduct. CIN: L93090KA1993PLC159827 www.bandaram.com, Reg office. We request you to take the above information on your records. Thanking you. Yours sincerely, For Bandaram Pharma Packtech Limited Deepak Reddy Bandaram Chairman and Managing Director (DIN: 07074102) CIN: L93090KA1993PLC159827 www.bandaram.com, Reg office.